amifuraline

Known as: 3-(5-(4,5-dihydro-1H-imidazol-2-yl)furan-2-yl)phenylamine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
On the basis of the observation that the central side effects of MAO inhibitors may represent a major limit for their use in… (More)
Is this relevant?